BioCentury
ARTICLE | Company News

Luye acquiring Acino's transdermal delivery business

July 26, 2016 7:00 AM UTC

Luye Pharma Group Ltd. (HKSE:2186) is to acquire the transdermal drug delivery systems (TDS) business from delivery play Acino Holding AG (Aesch, Switzerland) for EUR 245 million ($268.6 million). Luy...